C

CVRx Inc
NASDAQ:CVRX

Watchlist Manager
CVRx Inc
NASDAQ:CVRX
Watchlist
Price: 15.3 USD -1.48%
Market Cap: 371.2m USD
Have any thoughts about
CVRx Inc?
Write Note

CVRx Inc
Inventory

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CVRx Inc
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
C
CVRx Inc
NASDAQ:CVRX
Inventory
$11m
CAGR 3-Years
49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Inventory
$3.8B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Inventory
$2.8B
CAGR 3-Years
20%
CAGR 5-Years
12%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Inventory
$5.3B
CAGR 3-Years
16%
CAGR 5-Years
10%
CAGR 10-Years
12%
Abbott Laboratories
NYSE:ABT
Inventory
$6.8B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
10%
Intuitive Surgical Inc
NASDAQ:ISRG
Inventory
$1.5B
CAGR 3-Years
36%
CAGR 5-Years
21%
CAGR 10-Years
22%
No Stocks Found

CVRx Inc
Glance View

Market Cap
370.3m USD
Industry
Health Care

CVRx, Inc. develops proprietary active implantable technology to treat high blood pressure and heart failure. The company is headquartered in Minneapolis, Minnesota and currently employs 109 full-time employees. The company went IPO on 2021-06-30. The firm is focused on developing, manufacturing and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its platform technology offers BAROSTIM, designed to control the brain to address the imbalance of the autonomic nervous system (ANS), which causes heart failure (HF) and other cardiovascular diseases. The Company’s product, BAROSTIM NEO, is a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction (HFrEF). BAROSTIM NEO provides baroreflex activation therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. BAROSTIM NEO consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead.

CVRX Intrinsic Value
11.54 USD
Overvaluation 25%
Intrinsic Value
Price
C

See Also

What is CVRx Inc's Inventory?
Inventory
11m USD

Based on the financial report for Dec 31, 2023, CVRx Inc's Inventory amounts to 11m USD.

What is CVRx Inc's Inventory growth rate?
Inventory CAGR 3Y
49%

Over the last year, the Inventory growth was 57%. The average annual Inventory growth rates for CVRx Inc have been 49% over the past three years .

Back to Top